Citigroup Maintains Neutral Rating on Merck, Raises Price Target to $145
Citigroup maintained its Neutral rating on Merck and raised its price target to $145 per share from $125.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.